Para citar este trabalho use um dos padrões abaixo:
Alopecia, defined as total or partial hair loss is classified into scarring, non-scarring, and hair shaft disorders. Lupus is an autoimmune disease, characterized by an immune response imbalance, with 30-50% of patients experiencing alopecia and a predominance of T-lymphocytes in histopathological analysis. We aimed to identify scalp T-lymphocyte subpopulations in lupus patients and correlate them with clinical findings. This cross-sectional study (IRB# 69467223.0.0000.5243) evaluated scalp biopsies obtained from patients recruited through the Dermatology Departments of HUAP/EBSERH-UFF. Biopsies were performed by the clinical staff in areas of active lesions using a 6mm punch. The biopsies were fragmented and processed using a tissue dissociation protocol with IV collagenase, followed by cell purification and extracellular and intracellular staining using an 18-antibody flow cytometry panel (CD3, CD45, CD4, CD45RO, CD25, CD8, CD127, TCRγδ, CD103, CD69, CCR6, PD-1, CCR4, CD56, CD19, T-bet, Ki-67, and FOXP3), were then analyzed on a BD FACSymphony A5 cytometer (Fiocruz). Among 15 patients (mean age 55.6 ± 18.1 years; 86.7% women; 66.7% systemic lupus erythematosus), we found no cellular differences between systemic and cutaneous lupus, but significant differences were identified only after stratification based on the presence or absence of frontal hairline involvement, as no differences have yet been observed between those with and without scalp plaques. So, patients with frontal fibrosing alopecia (FFA)-like involvement (n=8) had a lower percentage of CD4+CD25+FOXP3+ Treg cells than non-FFA-like patients (9.52% vs 11.40%; p=0.028). Within the total Treg pool, the FFA-like group had fewer CD69+ cells than the non-FFA-like group (76.75% vs 88.40%; p=0.028). Conclusion: The decrease in CD4+CD25+FOXP3+CD69+ Tregs in FFA-like lupus suggests compromised local immunoregulatory capacity and reduced control of tissue inflammation. Further analyses are currently in progress.
Com ~200 mil publicações revisadas por pesquisadores do mundo todo, o Galoá impulsiona cientistas na descoberta de pesquisas de ponta por meio de nossa plataforma indexada.
Confira nossos produtos e como podemos ajudá-lo a dar mais alcance para sua pesquisa:
Esse proceedings é identificado por um DOI , para usar em citações ou referências bibliográficas. Atenção: este não é um DOI para o jornal e, como tal, não pode ser usado em Lattes para identificar um trabalho específico.
Verifique o link "Como citar" na página do trabalho, para ver como citar corretamente o artigo